Tene Kalyani, Kalyan Kumar M, Basveshwar G, Eswara Rao P, Jagadeesh Kumar G, Kumar Pramod, Pemmaraju Deepak B, Murty U S N, Gogoi Ranadeep, Naidu V G M
Department of Biotechnology, National Institute of Pharmaceutical Education and Research- Guwahati, Assam, India.
Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research-Guwahati, Assam, India.
Front Pharmacol. 2021 May 17;12:624706. doi: 10.3389/fphar.2021.624706. eCollection 2021.
Cardiovascular complications are the foremost concern in patients undergoing anticancer therapy There is an unmet need to address the problems arising from the drug-induced toxicity for the long-term benefit of the patients undergoing chemotherapy. Alternative medicines are gaining their prosperity in addressing the various drug-induced organ toxicity. Roxb (DP) is an ethnomedicinal plant rich in flavonoids and phenolic contents. In India & Nepal, DP is a common ingredient of traditional medicines used to treat multiple ailments like inflammation, cancer, and diabetes. However, its protective role against doxorubicin (Dox) induced cardiotoxicity remains unexplored. Herein, we investigated the potential effects of various extracts/fractions obtained from the DP's bark against Dox-induced cardiotoxicity, both and . The anti-oxidant content of the extracts/fractions was evaluated by using DPPH, ABTS and FRAP chemical assays. The results indicated that the hydroalcoholic (HA) extract of DP has intense anti-oxidant potential. Further fractionation of DP revealed that the phenolic-rich fraction (F1) has a high anti-oxidant potential. The protective effect of extract/fraction was also investigated in the H9c2 cell line following the Dox-induced cardiotoxicity model. We observed that the pre-treatment of extract/fraction in cardiomyocytes had exhibited increased cell viability. Fluorescence-based chemical assays indicated a decreased ROS levels in the treated groups in comparison to the Dox control group. The effect of DP was evaluated further in balb/c mice by the Dox-induced cardiotoxicity model. Non-invasive techniques like high-frequency ultrasonography and electrocardiogram revealed that the mice pre-treated with DP had improved cardiac functionality (left ventricular ejection fraction and stroke volume) and normalized the electrocardiograms compared to the Dox control group. Further, biochemical analysis with the cardiac tissues revealed that the cytoprotective proteins like HO-1, SOD-2, and Nrf-2 were elevated in the DP treated groups compared to the Dox control group. Overall, our results suggested that the bioactive extract/fractions of DP helped alleviate the Dox-induced cardiotoxicity. LC-QTOF-ESI-MS analysis of DP and F1 indicated that polyphenolic anti-oxidant compounds like gallic acid, syringic acid, and sinapic acid could be responsible for the potent -cardioprotective effect. Future understanding of the pharmacokinetics and pharmacodynamic parameters can help translate from the bench to the bedside.
心血管并发症是接受抗癌治疗患者最主要的担忧。为了让接受化疗的患者获得长期益处,解决药物诱导毒性所引发的问题存在未被满足的需求。替代药物在应对各种药物诱导的器官毒性方面正日益兴盛。毛脉酸模(Roxb (DP))是一种富含黄酮类和酚类成分的民族药用植物。在印度和尼泊尔,DP是用于治疗多种疾病如炎症、癌症和糖尿病的传统药物的常见成分。然而,其对阿霉素(Dox)诱导的心脏毒性的保护作用仍未被探索。在此,我们研究了从DP树皮中获得的各种提取物/馏分对Dox诱导的心脏毒性的潜在影响,包括体外和体内实验。通过使用DPPH、ABTS和FRAP化学分析法评估提取物/馏分的抗氧化含量。结果表明,DP的水醇提取物(HA)具有强烈的抗氧化潜力。对DP的进一步分级分离显示,富含酚类的馏分(F1)具有较高的抗氧化潜力。在Dox诱导的心脏毒性模型后的H9c2细胞系中也研究了提取物/馏分的保护作用。我们观察到,在心肌细胞中对提取物/馏分进行预处理后细胞活力增加。基于荧光的化学分析法表明,与Dox对照组相比,处理组中的活性氧水平降低。通过Dox诱导的心脏毒性模型在balb/c小鼠中进一步评估了DP的作用。高频超声心动图和心电图等非侵入性技术显示,与Dox对照组相比,用DP预处理的小鼠心脏功能(左心室射血分数和每搏输出量)得到改善,心电图恢复正常。此外,对心脏组织的生化分析显示,与Dox对照组相比,DP处理组中细胞保护蛋白如HO - 1、SOD - 2和Nrf - 2升高。总体而言,我们的结果表明,DP的生物活性提取物/馏分有助于减轻Dox诱导的心脏毒性。对DP和F1的LC - QTOF - ESI - MS分析表明,没食子酸、丁香酸和芥子酸等多酚类抗氧化化合物可能是其强大的心脏保护作用的原因。未来对药代动力学和药效学参数的了解有助于从实验室研究转化为临床应用。